Petros Pharmaceuticals PTPI
OTC PTPI
$0.00 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Petros Pharmaceuticals, Inc. (PTPI) EBITDA Margin (2020 - 2024)

Updated

Petros Pharmaceuticals' EBITDA Margin was -82.05% in Q2 2023, down 79.64 percentage points from -2.40% a year earlier and down 62.88 percentage points from the prior quarter.

Analysis

Petros Pharmaceuticals, Inc. (PTPI) EBITDA Margin (2020 - 2024) Analysis & Trends

On a trailing twelve-month basis, Petros Pharmaceuticals' EBITDA Margin was -452.05% through Jun 30, 2023, down 361.62 percentage points year-over-year; for FY2022, it came in at -238.93%, down 95.93 percentage points from FY2021.

  • In earlier years, EBITDA Margin was -143.00% in FY2021 (-31.89 pp) and -111.11% in FY2020.
  • Quarterly EBITDA Margin has moved between -399.05% (Q4 2022) and 43.80% (Q1 2022) over five years.
  • Compared with a year earlier, EBITDA Margin was higher in two of the last five quarters, with an average year-over-year change of -10.69 percentage points.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 317.44%
Sep 30, 2024 -603.96%
Jun 30, 2024 -528.74%
Mar 31, 2024 -517.12%
Dec 31, 2023 -1,861.27%
Sep 30, 2023 -2,362.19%
Jun 30, 2023 -82.05%
Mar 31, 2023 -19.16%
Dec 31, 2022 -399.05%
Jun 30, 2022 -2.40%
Mar 31, 2022 43.80%
Sep 30, 2021 -87.07%
Jun 30, 2021 -103.83%
Mar 31, 2021 -11.19%
Dec 31, 2020 -89.75%
Sep 30, 2020 -19.12%
Jun 30, 2020 -244.40%
Mar 31, 2020 -220.32%
API Access

Petros Pharmaceuticals, Inc. EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PTPI&period=max&api_key=YOUR_API_KEY